MEVACOR Side Effects

7007828-2 | Fatigue, Myalgia, Pain, Pain In Extremity, Paraesthesia
on Sep 16, 2010 Female patient from CANADA , 74 years of age, weighting 180.8 lb, was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, myalgia, pain (What is pain?), pain in extremity, paraesthesia. Mevacor dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), CRESTOR (View Crestor Review and Crestor Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), LOVAZA (View Lovaza Review and Lovaza Label ).

6955956-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Myoglobin Blood Increased, Myoglobin Urine Present, Pain, Urine Colour Abnormal
Patient was taking Mevacor (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, myoglobin blood increased, myoglobin urine present, pain (What is pain?), urine colour abnormal on Aug 23, 2010 from ITALY Additional patient health information: Male patient , 63 years of age, was diagnosed with hypercholesterolaemia, hypertension and. Mevacor dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ). Patient was hospitalized.

6614319-7 | Alopecia
Adverse event was reported on Mar 03, 2010 by a Female patient taking Mevacor (View Usage) (Dosage: 20 Mg 1 Daily Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 44 years of age, weighting 220.0 lb, After Mevacor was administered, patient had the following side effects: alopecia. During the same period patient was treated with ZOCOR (40 Mg 1 Daily Po) (View Zocor Review and Zocor Label ).

6519407-1 | Jaundice Cholestatic, Liver Injury
on Nov 03, 2009 Male patient from GERMANY , 48 years of age, weighting 189.6 lb, was diagnosed with hyperlipidaemia and was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice cholestatic, liver injury. Mevacor dosage: . During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.


6439799-1 | Blood Creatine Phosphokinase Increased
on Aug 11, 2009 Male patient from UNITED STATES , 79 years of age, was treated with Mevacor (View Usage). Patient had the following side effects: blood creatine phosphokinase increased. Mevacor dosage: . During the same period patient was treated with GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), LINEZOLID (View Linezolid Review and Linezolid Label ).

6439792-9 | Jaundice Cholestatic, Liver Injury
Patient was taking Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: jaundice cholestatic, liver injury on Nov 03, 2009 from GERMANY Additional patient health information: Male patient , 48 years of age, weighting 189.6 lb, was diagnosed with hyperlipidaemia and. Mevacor dosage: . During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

6437576-9 | Lip Blister, Stevens-johnson Syndrome
Adverse event was reported on Sep 08, 2008 by a Female patient taking Mevacor (View Usage) (Dosage: Po) was diagnosed with blood cholesterol and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: lip blister, stevens-johnson syndrome. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ).

6427179-4 | Renal Failure Acute
on Oct 20, 2009 Female patient from UNITED STATES , 69 years of age, was diagnosed with ischaemic stroke and was treated with Mevacor (View Usage). Patient had the following side effects: renal failure acute. Mevacor dosage: 6 Mg/kg/daily/po.

6417972-6 | Blood Creatine Phosphokinase Increased, Muscle Injury
on Oct 22, 2009 Female patient from UNITED STATES , 42 years of age, was diagnosed with blood cholesterol increased and was treated with Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: blood creatine phosphokinase increased, muscle injury. Mevacor dosage: . Patient was hospitalized.

6414077-5 | Rhabdomyolysis
Patient was taking Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis on Oct 22, 2009 from UNITED STATES Additional patient health information: Female patient , 80 years of age, . Mevacor dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), HEARTBURN PILL (View Heartburn Pill Review and Heartburn Pill Label ), ADVIL (View Advil Review and Advil Label ), SOMA (View Soma Review and Soma Label ). Patient was hospitalized.

6411103-4 | Bradycardia, Dysarthria, Urinary Tract Infection
Adverse event was reported on Sep 24, 2009 by a Male patient taking Mevacor (View Usage) (Dosage: 6 Mg/kg/daily/po) was diagnosed with ischaemic stroke and. Location: UNITED STATES , 72 years of age, Patient had the following side effects: bradycardia, dysarthria, urinary tract infection (What is urinary tract infection?).

6409009-X | Renal Failure Acute
on Sep 24, 2009 Female patient from UNITED STATES , 69 years of age, was diagnosed with ischaemic stroke and was treated with Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: renal failure acute. Mevacor dosage: 6 Mg/kg/daily/po.

6409003-9 | Bradycardia, Dysarthria, Urinary Tract Infection
on Sep 24, 2009 Male patient from UNITED STATES , 72 years of age, was diagnosed with ischaemic stroke and was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, dysarthria, urinary tract infection (What is urinary tract infection?). Mevacor dosage: 6 Mg/kg/daily/po.

6408549-7 | Renal Failure Acute
Patient was taking Mevacor (View Usage). Patient had the following side effects: renal failure acute on Sep 24, 2009 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with ischaemic stroke and. Mevacor dosage: 6 Mg/kg/daily/po.

6407853-6 | Blood Creatine Phosphokinase Increased, Muscle Injury
Adverse event was reported on Oct 14, 2009 by a Female patient taking Mevacor (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 43 years of age, After Mevacor was administered, patient had the following side effects: blood creatine phosphokinase increased, muscle injury. Patient was hospitalized.

6381019-0 | Rhabdomyolysis
on Sep 18, 2009 Male patient from SWEDEN , 51 years of age, was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Mevacor dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

6315209-X | Blood Creatine Phosphokinase Increased
on Aug 11, 2009 Male patient from UNITED STATES , 79 years of age, was treated with Mevacor (View Usage). Patient had the following side effects: blood creatine phosphokinase increased. Mevacor dosage: . During the same period patient was treated with GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), LINEZOLID (View Linezolid Review and Linezolid Label ).

6311877-7 | Amyotrophic Lateral Sclerosis, Myalgia
Patient was taking Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), myalgia on Aug 10, 2009 from UNITED STATES Additional patient health information: Female patient , 68 years of age, was diagnosed with hyperlipidaemia and. Mevacor dosage: .

6306545-1 | Alanine Aminotransferase Increased, Anxiety, Aspartate Aminotransferase Increased, Back Pain, Fall, Hypertension, Rhabdomyolysis, Weight Decreased
Adverse event was reported on Aug 06, 2009 by a Female patient taking Mevacor (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 75 years of age, weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anxiety (What is anxiety?), aspartate aminotransferase increased, back pain (What is back pain?), fall (What is fall?), hypertension, rhabdomyolysis, weight decreased. During the same period patient was treated with DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ). Patient was hospitalized.

6266024-7 | Alanine Aminotransferase Increased, Anxiety, Aspartate Aminotransferase Increased, Back Pain, Fall, Hypertension, Rhabdomyolysis, Weight Decreased
on Jul 01, 2009 Female patient from UNITED STATES , 75 years of age, weighting 183.0 lb, was diagnosed with hyperlipidaemia and was treated with Mevacor (View Usage). Patient had the following side effects: alanine aminotransferase increased, anxiety (What is anxiety?), aspartate aminotransferase increased, back pain (What is back pain?), fall (What is fall?), hypertension, rhabdomyolysis, weight decreased. Mevacor dosage: . During the same period patient was treated with DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ). Patient was hospitalized.

6254992-9 | Autoimmune Thyroiditis, Balance Disorder, Dermatitis Psoriasiform, Dysgeusia, Endocrine Disorder, Fall, Hypersensitivity, Myopathy, Oedema
on Jun 25, 2009 Female patient from GERMANY , 43 years of age, weighting 207.2 lb, was diagnosed with hypercholesterolaemia, otitis media and was treated with Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: autoimmune thyroiditis, balance disorder, dermatitis psoriasiform, dysgeusia, endocrine disorder, fall (What is fall?), hypersensitivity, myopathy, oedema. Mevacor dosage: . During the same period patient was treated with OFLOXACIN HYDROCHLORIDE (View Ofloxacin Hydrochloride Review and Ofloxacin Hydrochloride Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

6153208-1 | Headache, Influenza Like Illness, Palpitations
Patient was taking Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), influenza like illness, palpitations on Apr 07, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Mevacor dosage: . During the same period patient was treated with PRAVACHOL (View Pravachol Review and Pravachol Label ). Patient was hospitalized.

6128036-3 | Headache, Influenza Like Illness, Palpitations
Adverse event was reported on Mar 16, 2009 by a Female patient taking Mevacor (View Usage) (Dosage: ) . Location: UNITED STATES , 60 years of age, Patient had the following side effects: headache (What is headache?), influenza like illness, palpitations. During the same period patient was treated with PRAVACHOL (View Pravachol Review and Pravachol Label ). Patient was hospitalized.

6121938-3 | Focal Segmental Glomerulosclerosis, Myopathy, Nephrosclerosis, Renal Failure Chronic, Rhabdomyolysis
on Mar 05, 2009 Female patient from SINGAPORE , 16 years of age, was diagnosed with hypercholesterolaemia and was treated with Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: focal segmental glomerulosclerosis, myopathy, nephrosclerosis, renal failure chronic, rhabdomyolysis. Mevacor dosage: . During the same period patient was treated with ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ).

6115260-9 | Alanine Aminotransferase Increased, Anxiety, Aspartate Aminotransferase Increased, Back Pain, Rhabdomyolysis, Weight Decreased
on Mar 02, 2009 Female patient from UNITED STATES , 75 years of age, weighting 183.0 lb, was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anxiety (What is anxiety?), aspartate aminotransferase increased, back pain (What is back pain?), rhabdomyolysis, weight decreased. Mevacor dosage: . During the same period patient was treated with DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ). Patient was hospitalized.

6096484-6 | Amnesia, Fatigue, Gait Disturbance, Mobility Decreased, Walking Aid User
Patient was taking Mevacor (View Usage). Patient had the following side effects: amnesia, fatigue, gait disturbance, mobility decreased, walking aid user on Feb 25, 2009 from UNITED STATES Additional patient health information: Female patient , 73 years of age, weighting 118.0 lb, was diagnosed with blood cholesterol increased and. Mevacor dosage: 20 Mg 1 A Day. During the same period patient was treated with LOVASTATIN (20 Mg 1 A Day) (View Lovastatin Review and Lovastatin Label ).

5938671-0 | Upper Gastrointestinal Haemorrhage
Adverse event was reported on Oct 20, 2008 by a Male patient taking Mevacor (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, benign prostatic hyperplasia, hypertension, cardiac valve disease and. Location: SPAIN , 70 years of age, After Mevacor was administered, patient had the following side effects: upper gastrointestinal haemorrhage. During the same period patient was treated with DUTASTERIDE (View Dutasteride Review and Dutasteride Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), ALFUZOSIN HYDROCHLORIDE (View Alfuzosin Hydrochloride Review and Alfuzosin Hydrochloride Label ). Patient was hospitalized.

5931335-9 | Upper Gastrointestinal Haemorrhage
on Oct 20, 2008 Male patient from SPAIN , 70 years of age, was diagnosed with hypercholesterolaemia, benign prostatic hyperplasia, hypertension, cardiac valve disease and was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: upper gastrointestinal haemorrhage. Mevacor dosage: . During the same period patient was treated with DUTASTERIDE (View Dutasteride Review and Dutasteride Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), ALFUZOSIN HYDROCHLORIDE (View Alfuzosin Hydrochloride Review and Alfuzosin Hydrochloride Label ). Patient was hospitalized.

5760238-8 | Anaemia Of Chronic Disease, Aortic Valve Replacement, Bladder Neoplasm, Cerebral Infarction, Coronary Artery Disease, Disease Recurrence, Myocardial Infarction, Osteoarthritis, Pancreatic Neoplasm
on May 19, 2008 Female patient from UNITED STATES , 71 years of age, weighting 115.0 lb, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Mevacor (View Usage). Patient had the following side effects: anaemia of chronic disease, aortic valve replacement, bladder neoplasm, cerebral infarction, coronary artery disease (What is coronary artery disease?), disease recurrence, myocardial infarction, osteoarthritis (What is osteoarthritis?), pancreatic neoplasm. Mevacor dosage: 80 Mg/daily/po. During the same period patient was treated with LASOFOXIFENE UNK (0.5 Mg/daily/po) (View Lasofoxifene Unk Review and Lasofoxifene Unk Label ), COZAAR (View Cozaar Review and Cozaar Label ), OS CAL (View Os-cal Review and Os-cal Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), INSULIN HUMAN, ISOPHANE (View Insulin Human, Isophane Review and Insulin Human, Isophane Label ). Patient was hospitalized.

5622211-X | Cerebral Thrombosis, Cerebrovascular Accident, Convulsion, Dysarthria, Fatigue, Gait Disturbance, Grip Strength Decreased, Hallucination, Auditory, Hemiplegia
Patient was taking Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: cerebral thrombosis, cerebrovascular accident, convulsion, dysarthria, fatigue, gait disturbance, grip strength decreased, hallucination, auditory, hemiplegia on Feb 04, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 169.1 lb, was diagnosed with blood cholesterol, diabetes mellitus, hypertension, thrombosis prophylaxis and. Mevacor dosage: 80 Mg. During the same period patient was treated with DIPYRIDAMOLE (Unk) (View Dipyridamole Review and Dipyridamole Label ), FELODIPINE (Unk) (View Felodipine Review and Felodipine Label ), METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), LASIX (80 Mg) (View Lasix Review and Lasix Label ), ATENOLOL (100 Mg) (View Atenolol Review and Atenolol Label ), PLAVIX (View Plavix Review and Plavix Label ).

5618607-2 | Gait Disturbance, Pain In Extremity, Plantar Fasciitis
Adverse event was reported on Feb 05, 2008 by a Female patient taking Mevacor (View Usage) (Dosage: 1 Tabet 1xd Po) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 63 years of age, weighting 164.0 lb, Patient experienced the following unwanted or unexpected effects: gait disturbance, pain in extremity, plantar fasciitis.

5596355-5 | Completed Suicide, Overdose
on Jan 10, 2008 Male patient from UNITED STATES , 48 years of age, was treated with Mevacor (View Usage). Patient had the following side effects: completed suicide, overdose. Mevacor dosage: . During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), VARDENAFIL (View Vardenafil Review and Vardenafil Label ).

5583608-X | Completed Suicide, Overdose
on Dec 31, 2007 Male patient from UNITED STATES , 48 years of age, was treated with Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: completed suicide, overdose. Mevacor dosage: . During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), VARDENAFIL (View Vardenafil Review and Vardenafil Label ).

5580127-1 | Bedridden, Economic Problem, Fall, Ill-defined Disorder, Muscle Contractions Involuntary, Neuropathy, Paraesthesia
Patient was taking Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: bedridden, economic problem, fall (What is fall?), ill-defined disorder, muscle contractions involuntary, neuropathy, paraesthesia on Dec 27, 2007 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 250.0 lb, was diagnosed with blood cholesterol and. Mevacor dosage: .

5575535-9 | Gallbladder Disorder, Myalgia
Adverse event was reported on Dec 20, 2007 by a Male patient taking Mevacor (View Usage) (Dosage: ) was diagnosed with blood cholesterol and. Location: UNITED STATES , 62 years of age, Patient had the following side effects: gallbladder disorder, myalgia. During the same period patient was treated with HYDRODIURIL (View Hydrodiuril Review and Hydrodiuril Label ), PRINIVIL (View Prinivil Review and Prinivil Label ). Patient was hospitalized and became disabled.

5574704-1 | Amyotrophic Lateral Sclerosis, Liver Function Test Abnormal, Muscle Spasms, Myalgia
on Dec 21, 2007 Male patient from UNITED STATES , 52 years of age, weighting 205.0 lb, was treated with Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), liver function test abnormal, muscle spasms, myalgia. Mevacor dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ZETIA (View Zetia Review and Zetia Label ), ZOCOR (View Zocor Review and Zocor Label ), CRESTOR (View Crestor Review and Crestor Label ).

5557824-7 | Cerebrovascular Accident, Constipation, Diplopia, Muscle Spasms, Oedema Peripheral
on Dec 11, 2007 Male patient from UNITED STATES , 63 years of age, was diagnosed with blood cholesterol increased and was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, constipation (What is constipation?), diplopia, muscle spasms, oedema peripheral. Mevacor dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ).

5530797-9 | Amyotrophic Lateral Sclerosis, Dysphagia, Speech Disorder
Patient was taking Mevacor (View Usage). Patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), dysphagia, speech disorder on May 16, 1996 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with hypercholesterolaemia and. Mevacor dosage: .

5517930-X | Muscular Weakness
Adverse event was reported on Apr 19, 2007 by a Male patient taking Mevacor (View Usage) (Dosage: Po) was diagnosed with hypercholesterolaemia and. Location: UNITED STATES , 60 years of age, After Mevacor was administered, patient had the following side effects: muscular weakness.

5517929-3 | Back Pain, Blood Cholesterol Increased, Muscle Spasms, Neck Pain, Stevens-johnson Syndrome
on May 03, 2007 Male patient from UNITED STATES , 64 years of age, was diagnosed with hypercholesterolaemia and was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), blood cholesterol increased, muscle spasms, neck pain, stevens-johnson syndrome. Mevacor dosage: 20 Mg/daily/po 40 Mg/daily Po. During the same period patient was treated with DISALCID (View Disalcid Review and Disalcid Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), MOTRIN (View Motrin Review and Motrin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

5517928-1 | Myalgia, Myopathy
on Apr 23, 2007 Female patient from UNITED STATES , 65 years of age, was treated with Mevacor (View Usage). Patient had the following side effects: myalgia, myopathy. Mevacor dosage: Po. During the same period patient was treated with ALPHAGAN (View Alphagan Review and Alphagan Label ), AVANDIA (View Avandia Review and Avandia Label ), COSOPT (View Cosopt Review and Cosopt Label ), DETROL LA (View Detrol La Review and Detrol La Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), ELAVIL (View Elavil Review and Elavil Label ), LANTUS (View Lantus Review and Lantus Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5517927-X | Hepatic Steatosis, Hepatitis, Rhabdomyolysis
Patient was taking Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: hepatic steatosis, hepatitis (What is hepatitis?), rhabdomyolysis on May 24, 2007 from UNITED STATES Additional patient health information: Male patient , 84 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Mevacor dosage: Po. During the same period patient was treated with KETOCONAZOLE (400 Mg/tid/po) (View Ketoconazole Review and Ketoconazole Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ).

5517926-8 | Hepatitis
Adverse event was reported on Jul 17, 2007 by a Female patient taking Mevacor (View Usage) (Dosage: 20-40 Mg/daily/po) was diagnosed with blood cholesterol increased and. Location: UNITED STATES , 52 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). During the same period patient was treated with CALAN (View Calan Review and Calan Label ), ISORDIL (View Isordil Review and Isordil Label ), MICRONASE (View Micronase Review and Micronase Label ), TAGAMET (View Tagamet Review and Tagamet Label ). Patient was hospitalized.

5517925-6 | Asthenia
on Aug 07, 2007 Male patient from UNITED STATES , 41 years of age, was treated with Mevacor (View Usage). Patient had the following side effects: asthenia. Mevacor dosage: 60 Mg/hs/po ; Po. Patient was hospitalized.

5492090-2 | Poor Peripheral Circulation
on Oct 11, 2007 Female patient from UNITED STATES , 65 years of age, was treated with Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: poor peripheral circulation. Mevacor dosage: .

5481939-5 | Encephalopathy, Hepatic Failure, Hepatitis
Patient was taking Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy, hepatic failure, hepatitis (What is hepatitis?) on Jun 18, 1991 from SPAIN Additional patient health information: Female patient , 51 years of age, was diagnosed with hypercholesterolaemia and. Mevacor dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

5479964-3 | Chromaturia, Hepatic Failure, Jaundice
Adverse event was reported on Apr 16, 1998 by a Female patient taking Mevacor (View Usage) (Dosage: ) . Location: UNITED STATES , 52 years of age, Patient had the following side effects: chromaturia, hepatic failure, jaundice (What is jaundice?). During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), DIABETA (View Diabeta Review and Diabeta Label ), PREMARIN (View Premarin Review and Premarin Label ). Patient was hospitalized.

5474822-2 | Myopathy, Pain
on Sep 21, 2007 Male patient from UNITED STATES , 69 years of age, was diagnosed with dyslipidaemia and was treated with Mevacor (View Usage). After Mevacor was administered, patient had the following side effects: myopathy, pain (What is pain?). Mevacor dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), LASIX (View Lasix Review and Lasix Label ), PROZAC (View Prozac Review and Prozac Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), COUMADIN (View Coumadin Review and Coumadin Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ). Patient was hospitalized.

5453187-6 | Alanine Aminotransferase Increased, Angina Pectoris, Aspartate Aminotransferase Increased, Bundle Branch Block Right, Coronary Artery Occlusion, Diabetes Mellitus, Gastrooesophageal Reflux Disease
on Sep 04, 2007 Male patient from UNITED STATES , 68 years of age, weighting 167.6 lb, was diagnosed with hypercholesterolaemia, angina pectoris and was treated with Mevacor (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, angina pectoris, aspartate aminotransferase increased, bundle branch block right, coronary artery occlusion, diabetes mellitus, gastrooesophageal reflux disease. Mevacor dosage: . During the same period patient was treated with RANEXA (View Ranexa Review and Ranexa Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), PLAVIX (View Plavix Review and Plavix Label ), UBIDECARENONE (View Ubidecarenone Review and Ubidecarenone Label ). Patient was hospitalized.

5444049-9 | Anger, Anxiety, Asthenia, Depression, Dizziness, Fall, Fear, Feeling Abnormal, Feeling Of Despair
Patient was taking Mevacor (View Usage). Patient had the following side effects: anger, anxiety (What is anxiety?), asthenia, depression (What is depression?), dizziness (What is dizziness?), fall (What is fall?), fear, feeling abnormal, feeling of despair on Aug 28, 2007 from UNITED STATES Additional patient health information: Male patient , 42 years of age, weighting 244.7 lb, was diagnosed with hypercholesterolaemia, lipids increased and. Mevacor dosage: .